Risk of primary infection and reinfection with respiratory syncytial virus
- PMID: 3706232
- DOI: 10.1001/archpedi.1986.02140200053026
Risk of primary infection and reinfection with respiratory syncytial virus
Abstract
Respiratory syncytial virus is the most important cause of serious lower respiratory tract infection in children. For children followed up from birth in the Houston Family Study, the infection rate was 68.8/100 children less than 12 months of age and 82.6/100 during the second year of life. Virtually all children had been infected at least once by 24 months of age, and about one half had experienced two infections. Although lower respiratory tract disease (LRD) was common (22.4/100 during year 1 and 13.0/100 during year 2), most children had only one LRD illness. The risk of reinfection was inversely related to the level of neutralizing antibodies in the serum. Reinfection illnesses were generally mild, and risk of reinfection decreased to only 33.3/100 during year 4. Studies of children with LRD and surveys of hospitalizations provide the basis for an estimate of the number of children hospitalized each year during the respiratory syncytial virus epidemics. Almost 100,000 children in the United States experience an illness of sufficient severity to require hospitalization.
Similar articles
-
Influenza in children. Relationship to other respiratory agents.JAMA. 1980 Apr 4;243(13):1345-9. doi: 10.1001/jama.243.13.1345. JAMA. 1980. PMID: 6244421
-
Respiratory syncytial virus infection in children with bronchopulmonary dysplasia.Pediatrics. 1988 Aug;82(2):199-203. Pediatrics. 1988. PMID: 3399292
-
The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae.Am J Epidemiol. 1975 Jun;101(6):532-51. doi: 10.1093/oxfordjournals.aje.a112125. Am J Epidemiol. 1975. PMID: 168766
-
Pulmonary infections with respiratory syncytial virus and the parainfluenza viruses.Semin Respir Infect. 1987 Jun;2(2):112-21. Semin Respir Infect. 1987. PMID: 2827280 Review.
-
Detection, pathogenesis, and therapy of respiratory syncytial virus infections.Clin Microbiol Rev. 1988 Jan;1(1):27-39. doi: 10.1128/CMR.1.1.27. Clin Microbiol Rev. 1988. PMID: 3060243 Free PMC article. Review.
Cited by
-
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19.Front Pharmacol. 2020 Aug 19;11:1258. doi: 10.3389/fphar.2020.01258. eCollection 2020. Front Pharmacol. 2020. PMID: 32973505 Free PMC article. Review.
-
Characterization of the resistance of SJL/J mice to pneumonia virus of mice, a model for infantile bronchiolitis due to a respiratory syncytial virus.PLoS One. 2012;7(10):e44581. doi: 10.1371/journal.pone.0044581. Epub 2012 Oct 15. PLoS One. 2012. PMID: 23077483 Free PMC article.
-
The Future of Respiratory Syncytial Virus Disease Prevention and Treatment.Infect Dis Ther. 2021 Mar;10(Suppl 1):47-60. doi: 10.1007/s40121-020-00383-6. Epub 2021 Mar 3. Infect Dis Ther. 2021. PMID: 33656652 Free PMC article. Review.
-
IL-4Rα on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates.J Leukoc Biol. 2013 Jun;93(6):933-42. doi: 10.1189/jlb.1012498. Epub 2013 Mar 29. J Leukoc Biol. 2013. PMID: 23543769 Free PMC article.
-
Prolonged sinoatrial block in an infant with respiratory syncytial viral bronchiolitis.Pediatr Cardiol. 2012 Oct;33(7):1203-5. doi: 10.1007/s00246-012-0250-7. Epub 2012 Mar 3. Pediatr Cardiol. 2012. PMID: 22395651
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources